It’s a blow for GSK, which hopes that Trelegy (fluticasone furoate+umeclidinium+vilanterol ... for years thanks to its ageing asthma and COPD inhaler Advair, which finally succumbed to generic ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations have increased by an average 98% since they hit the market, according to ...

Objective: Single inhaler triple therapy is widely used in Chronic Obstructive Pulmonary Disease (COPD) and asthma. This research aimed to analyze adverse events (AEs ...

Prescribing information for Relvar Ellipta (fluticasone furoate/vilanterol) and adverse events reporting ... molecular properties, and inhaler device choice impacts treatment outcomes, drawing on real ...

Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...

Shanon and William Schmidtknecht, of Poynette, filed their lawsuit in federal court in Milwaukee on Jan. 21, a year to the ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma ...